Sarmazenil

From WikiMD's WELLNESSPEDIA

Sarmazenil


Sarmazenil is a benzodiazepine derivative drug that is a partial inverse agonist of the GABA_A receptor. It was developed by Hoffmann-La Roche in the 1980s as a potential treatment for benzodiazepine dependence and withdrawal syndrome.

Pharmacology[edit]

Sarmazenil acts as a partial inverse agonist at the GABA_A receptor, meaning it produces effects opposite to those of benzodiazepine drugs, which are GABA_A receptor agonists. This makes it useful in the treatment of benzodiazepine dependence and withdrawal syndrome, as it can help to reverse the effects of benzodiazepine drugs and reduce withdrawal symptoms.

Clinical Use[edit]

Sarmazenil has been studied in clinical trials for the treatment of benzodiazepine dependence and withdrawal syndrome. However, it has not been widely adopted in clinical practice, possibly due to its partial inverse agonist activity, which can potentially cause withdrawal symptoms in patients who are dependent on benzodiazepines.

Side Effects[edit]

As a partial inverse agonist of the GABA_A receptor, sarmazenil can potentially cause side effects such as anxiety, restlessness, and insomnia. These side effects are similar to those of benzodiazepine withdrawal syndrome, which can make it difficult to distinguish between the effects of the drug and the symptoms of withdrawal.

See Also[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.